[1]
Farzona Aripdzhanova, Tran., “CLINICAL COURSE AND TREATMENT CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE”, UOC, no. 11, Apr. 2026, Accessed: Sep. 12, 2026. [Online]. Available: https://openconf.uz/conf/article/view/376